Severn Pathology in Bristol has recently gone live with its fourth LIAISON XL system. What makes this one a bit more special is that it marks production of Diasorin’s 7,000th LIAISON XL instrument.
This remarkable milestone is a testament to Diasorin’s commitment to empowering clinical laboratories and healthcare providers.
The laboratory is utilising this instrument as part of the NHS blood-borne viruses opt-out testing programme underway in its emergency department, as well as latent TB testing using the LIAISON QuantiFERON-TB Gold Plus fully automated assay. Diasorin is proud that its products can be used in such impactful healthcare initiatives.
The LIAISON XL is more than just a piece of equipment; it's a partner in patient care. By automating complex tests and delivering fast, reliable results, it helps health-care professionals make informed decisions and improve patient outcomes.
LIAISON XL pairs powerful yet simple diagnostics technology with high sensitivity and precision, streamlining workflows and contributing to optimisation of the patient care protocol. LIAISON XL allows the laboratory to achieve more with fewer resources, thus reducing staff pressure while maintaining the standard of excellence regardless of patient testing volume.
For more information, please visit www.diasorin.com.